olaratumab

Ligand id: 9172

Name: olaratumab

References
1. Loizos N, Huber J. (2012)
Antibodies against PDGFRa.
Patent number: US8128929. Assignee: Imclone Llc. Priority date: 17/06/2006. Publication date: 06/04/2012.
2. Loizos N, Xu Y, Huber J, Liu M, Lu D, Finnerty B, Rolser R, Malikzay A, Persaud A, Corcoran E et al.. (2005)
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target.
Mol. Cancer Ther.4 (3): 369-79. [PMID:15767546]